Relevium Medical raises €4.6M Growth round
27 November 2024· Galway, Ireland· biotech, pharmaceuticals, materials, drug_delivery, b2b
The funding was awarded through the Disruptive Technologies Innovation Fund (DTIF) to develop an immediate and long-lasting treatment for knee osteoarthritis through their 'RestOAre' project.
Investors
LeadDisruptive Technologies Innovation Fund (DTIF)
Also participating
Enterprise IrelandDepartment of EnterpriseTrade and Employment
About Relevium Medical
Stage
Growth
Headquarters
Galway, Ireland
Founded
2019
Team Size
6–20
Sectors
biotechpharmaceuticalsmaterialsdrug_deliveryb2b